About
As a Managing Director at H.I.G. BioVentures, Bruce focuses on investment opportunities in the life sciences sector, including biopharmaceuticals, medical devices, and diagnostics. Bruce currently serves on the boards of Apollo Endosurgery, CardioFocus, Cerephex, and Clarus Therapeutics. Bruce has been active in the life sciences sector for more than 20 years. Prior to joining H.I.G., Bruce served most recently as Managing Director at Toucan Capital, an early-stage venture capital fund focusing on life science investments. While at Toucan, Bruce invested in leading drug and device companies throughout the U.S. Prior to Toucan, Bruce was a General Partner at GIV Venture Partners, a venture capital firm focused on early stage investments in the US, India, and China. Prior to his venture capital career, Bruce was Director of Business Development at IGEN International, where he was responsible for formulating and implementing IGEN's partnering and M&A strategies. Bruce started his career
Position in the VCSift Database
- • 2 investors at H.I.G. BioHealth Partners are tracked.
- • 1,801 investors hold the Managing Director role in VCSift. Bruce Robertson is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
Find more investors like Bruce
Search Investors